Next Article in Journal
The Importance of Toll-like Receptor 9 Expression on Monocytes and Dendritic Cells in the Context of Epstein–Barr Virus Infection in the Immunopathogenesis of Primary Glomerulonephritis
Next Article in Special Issue
Aphid BCR4 Structure and Activity Uncover a New Defensin Peptide Superfamily
Previous Article in Journal
Special Issue on “Raman Spectroscopy for Chemical and Structural Characterization in Biology”
Previous Article in Special Issue
Sunscreen Ingredient Octocrylene’s Potency to Disrupt Vitamin D Synthesis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

First Report on the Streptococcus gallolyticus (S. bovis Biotype I) DSM 13808 Exopolysaccharide Structure

by
Anna Maciejewska
*,
Czeslaw Lugowski
and
Jolanta Lukasiewicz
Laboratory of Microbial Immunochemistry and Vaccines, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2022, 23(19), 11797; https://doi.org/10.3390/ijms231911797
Submission received: 14 September 2022 / Revised: 30 September 2022 / Accepted: 3 October 2022 / Published: 5 October 2022
(This article belongs to the Collection Feature Papers in 'Macromolecules')

Abstract

:
Streptococcus gallolyticus subspecies gallolyticus, known as Streptococcus bovis biotype I, is a facultative pathogen causing bacteraemia, infective endocarditis and sepsis that has been linked with colorectal cancer (CRC), but this correlation is still unclear. Bacterial surface structures, such as the major sugar antigens exposed to the outside of the microorganism, are potential virulence factors. One of the primary sugar antigens loosely attached to the cell surface is the biofilm component, exopolysaccharide (EPS). EPSs of S. bovis are poorly characterized molecules. Until now, only one S. macedonicus Sc136 EPS structure was known to the entire S. bovis group. The S. gallolyticus DSM 13808 EPS was investigated by chemical analysis, mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. The hexasaccharide repeating unit of the EPS, containing four Glc, two Rha residues and one phosphate group, has been described “ →6)-α-d-Glcp-(1→3)-β-l-Rhap-(1→4)-β-d-Glcp-(1→3)-[β-d-Glcp-(1→2)]-α-l-Rhap-(1→2)-α-d-Glcp-(1→P→”.

1. Introduction

Association of infections caused by specific pathogens with neoplasms development is currently interesting and a promising research trend. Evidence for a connection between microorganisms and diseases, e.g., the human papillomavirus (HPV) responsible for cervical cancer development [1], or Helicobacter pylori, which is a known risk factor for gastric cancer of the intestinal type [2], has been found. Another example is Streptococcus bovis—a facultative pathogen causing bacteraemia, endocarditis and sepsis that has been linked with colorectal cancer (CRC) since the 1950s, but this correlation is still unclear. Worldwide, CRC is one of the major medical problems. It ranks as the third most common malignant neoplastic disease after breast and lung cancer in women and prostate and lung cancer in men [3,4]. Following lung cancer, CRC is the second highest cause of global cancer mortality, with an estimated 9.4% of cancer deaths in 2020 [5].
S. bovis is a Gram-positive bacterium and a gastrointestinal commensal found in animals and 16% of healthy people [6]. The most recent taxonomy identified the following species and subspecies among S. bovis: S. gallolyticus divided into subspecies gallolyticus (biotype I), pasteurianus (biotype II/2), macedonicus and S. infantarius with the subspecies infantarius (biotype II/1) and coli (also called lutetiensis) (biotype II/1) [7]. Due to the medical aspects, the greatest interest of researchers is focused on S. gallolyticus subspecies gallolyticus (Sgg) as 24% of streptococcal endocarditis is caused by Sgg. It has been shown that 65% of patients with infections caused by these bacteria are diagnosed with colorectal cancer [8]. Butt et al. demonstrated that risk of CRC is increased in individuals with serum antibody response to Sgg pilus protein [9]. To date, little is known about factors determining the relationship between CRC and S. bovis. In vitro and in vivo mouse models [10] demonstrated that S. gallolyticus actively promotes proliferation of human colon cancer cells depending on the growth phase of bacteria, direct contact of bacterial antigens with cells and from β-catenin (a key host molecule in the development of CRC). Not all CRC cell lines were sensitive to Sgg, suggesting that host traits may also have importance. Bacterial surface structures, such as piluses (Pil1, Pil2, Pil3), or the major sugar antigens exposed to the outside of the microorganism are potential virulence factors of Sgg [11]. Boleij et al. [12] hypothesized polysaccharide capsule- and piluslike structures as the main determinants of Sgg-specific association with endocarditis and CRC. The authors suggested the importance of these factors in observed low adhesiveness, inability to internalize epithelial cells by Sgg and biofilm formation on collagen-rich surfaces. Recently, Taylor et al. showed that the type VII secretion system (SggT7SST05), being important in bacterial virulence and persistent infection, is significant for Sgg adherence to CRC cells and stimulation of CRC cell proliferation [13].
As polysaccharide surface antigens were indicated among potential factors involved in association between Sgg and CRC, it is important to investigate sugar antigens characteristic of Sgg. One of the major sugar antigens loosely attached to the cell surface is exopolysaccharide (EPS). Being a long-chain homopolymer or heteropolymer composed of oligosaccharide repeating units is essential for protective function against environmental and biological factors. It plays an important role in forming of biofilm and enabling life in mono- or multi-species communities.
Knowledge regarding the composition, architecture and structure of the bacterial cell envelope in S. bovis group is inadequate. It is known that S. bovis produces capsules containing a large amount of α-d-glucose polymers [14] and lipoteichoic acid, but the complete structure of EPS for this bacterium is known only for one strain: S. macedonicus Sc136 [15].
Therefore, the aim of this study was to extend the knowledge concerning structural features of S. bovis and to investigate the structure of the new EPS of the S. gallolyticus subsp. gallolyticus strain DSM 13808 as an introduction to further research into S. bovis virulence factors and their possible correlation with CRC.

2. Results

2.1. Isolation of S. gallolyticus subsp. gallolyticus DSM 13808 Exopolysaccharide

The EPS was isolated from bacterial cells (4.69 g) by trichloroacetic acid extraction, ethanol precipitation and then purified according to the method described by Gorska et al. [16], with a slight modification—ion exchange chromatography was not used. After DNAse, RNAse and protease treatment, EPS (46.5 mg) was purified by gel filtration on a HiLoad 16/600 Superdex 30 pg column. The first predominant fraction (3.6 mg) was used for further analysis. The average molecular weight of the EPS was estimated by gel permeation chromatography to be approximately 11.7 kDa.

2.2. Structure of the Exopolysaccharide

Sugar and methylation analyses of the EPS, together with determination of the absolute configuration, showed the presence of terminal d-Glcp, 2-substituted d-Glcp, 4-substituted d-Glcp, 3-substituted l-Rhap and 2,3-disubstituted l-Rhap in the ratio 1:1.8:0.6:0.7:0.3. Further analysis indicated the presence of 6-substituted d-Glcp, not observed in methylation analysis due to phosphate substitution.
Preliminary one-dimensional (1D) 1H nuclear magnetic resonance (NMR) analysis of the EPS showed the presence of six major anomeric protons (A1-F1) and CH3 signals (B6, D6) characteristic of deoxysaccharides (Figure 1).
The EPS was further analysed using two-dimensional (2D) 1H,13C-NMR spectroscopy. All the spin systems were assigned using a combination of COSY, TOCSY with different mixing times, HSQC-DEPT, HSQC-TOCSY, NOESY and HMBC spectra (Figure 2), and by comparison with previously reported NMR data for respective monosaccharides [17,18]. Chemical shift values and the identified inter-residue connectivities for the EPS are presented in Table 1.
The NMR analysis showed six major signals representing hexasaccharide repeating unit of EPS (residues A, B, C, D, E and F) (Figure 1 and Figure 2 and Table 1).
Residue A with the H1/C1 signals at δ 5.58/95.5 ppm, JC-1,H-1~173 Hz was recognised as the 2-substituted α-d-Glcp residue based on the downfield shift of the C2 signals (79.7 ppm) and the strong vicinal couplings between H2, H3, H4 and H5.
Residue B with the H1/C1 signals at δ 5.29/102.2 ppm, JC-1,H-1~176 Hz was assigned as the 2,3-disubstituted α-l-Rhap from the high chemical shifts of the C2 (79.4 ppm) and C3 (80.7 ppm) and the signals for an exocyclic CH3 group (1.33 ppm, 17.7 ppm).
Residue C with the H1/C1 signals at δ 5.10/96.5 (JC-1,H-1~170 Hz) was recognized as the 6-substituted α-d-Glcp based on the large vicinal couplings between all ring protons and the characteristic downfield shift of the C6 signal (64.9 ppm).
Residue D with the H1/C1 signals at δ 4.88/101.4 (JC-1,H-1~162 Hz) was recognized as the 3-substituted β-l-Rhap based on the high chemical shifts of the C-3 (78.6 ppm) and the characteristic shift for an exocyclic CH3 group (1.34 ppm, 17.6 ppm).
Residue E with the H1/C1 signals at δ 4.72/104.7 (JC-1,H-1~161 Hz) was assigned as terminal β-d-Glcp according to coupling constants between all protons in the sugar ring.
Residue F with the H1/C1 signals at δ 4.71/104.5 (JC-1,H-1~163 Hz) was assigned as 4-substituted β-d-Glcp according to downfield shift of the C-4 at δ 77.4 ppm.
The HMBC 1H-31P NMR spectrum (Figure 3) of the EPS showed the presence of the glycosidically linked phosphate group (P). The 1H-31P correlations between the 31P signal at δP −1.02 ppm and H1 of A (2-substituted α-d-Glcp) and H6a and H6b of C (6-substituted α-d-Glcp) indicated the phosphodiester group. The 31P signal at δP 0.95 ppm showed connectivity to H6a and H6b of residue C′, which is a variant of C residue, indicating phosphomonoester at the non-reducing end of the EPS.
Residues A′ (H1/C1 signals at δ 5.31/92.2 ppm) and A″ (H1/C1 signals at δ 4.71/95.6 ppm) were recognized as α and β variants of residue A (2-substituted α-d-Glcp-(1→P) devoid of the phosphate group at the reducing end of the EPS, which affected adjacent residues B′ (H1/C1 signals at δ 5.26/102.2 ppm) and B″ (H1/C1 signals at δ 5.39/101.0 ppm), recognized as variants of residue B (2,3-disubstituted α-l-Rha).
The sequence of sugar residues in the EPS was identified by HMBC (Figure 2, Table 1) and NOESY (Table 1) experiments; the revealed structure is presented in Figure 1.

2.3. Mass Spectrometry Analysis of the EPS

The elucidated structure of the EPS isolated from S. gallolyticus DSM 13808 was confirmed by matrix-assisted laser-desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry. The mass spectrum of the partially hydrolysed EPS (Figure 4A) showed ions at m/z 981.32 [M + H, Na]+ and m/z 963.31 [M–H2O + H, Na]+. These ions correspond to the repeating unit (RU) built of four Glc and two Rha molecules, which, together, give a calculated monoisotopic mass of 958.34 Da. Ions at m/z 1061.29 [M + H, Na]+ and m/z 1083.27 [M + H, 2Na]+ represent four Glc and two Rha residues, and, additionally, one phosphate group as a compound of the repeating unit. Furthermore, the less abundant ions at m/z 1921.66 [M + H, Na]+, m/z 2023.61 [M + H, 2Na]+ and m/z 2125.54 [M + H, 3Na]+ indicated structures built of two RUs, two RUs with one phosphate group and two RUs with two phosphate group, respectively.
Additionally, the presence and sequence of sugars and location of the phosphate group (P) in the EPS was indicated by MALDI-TOF tandem mass spectrometry (MS/MS) analysis of the ion at m/z 1061.29 (Figure 4). The MS/MS fragmentation spectrum consisted of ions at m/z 264.84 [Glc·P, Z1], m/z 410.87 [Rha·Glc·P, Y/Y], m/z 572.90 [Glc·Rha·Glc·P, Z], m/z 718.98 [Rha·Glc·Rha·Glc·P, Z/Y] and m/z 881.12 [Glc·Rha·Glc·Rha·Glc·P, Z], indicated locations of P at the Glc residue and supported the sequence of the identified monosaccharides. An interpretation of the observed ions with mass spectra is shown in Table 2.

3. Discussion

Exopolysaccharides play an important role as components of biofilm involved in cell adhesion to surfaces. These macromolecules protect microorganisms against mechanical damage and dehydration but also against external environment stressors, such as temperature, pH, salinity, pressure, heavy metals, radiation and a host’s immune defence and biological factors, e.g., bacteriocins, bacteriophages and antibiotics. Bacterial EPSs exhibit various properties, with commercial applications in the medicine, pharmaceutical and food industries, agriculture and soil remediation. It is worth noting that biomedical properties of bacterial EPSs, e.g., Paenibacillus polymyxa curdlan sulphate, allow for using it as a vaccine against infection of hepatitis B virus and treatment of severe malaria [20]. Lactobacillus plantarum 70810 EPS inhibits proliferation of tumour cells, such as HepG-2, BGC-823 and HT-29 [21]. Nostoc sp. EPS was used as an aerogel for drug delivery and tissue engineering [22]. Exopolysaccharides of probiotic bacteria have immunomodulatory activities, providing health benefits to the host [23,24,25]. Due to these applications, chemical, physicochemical and biological studies of EPSs are very important subjects.
Little is known about biofilm of Sgg that may contribute to chronic inflammation and the CRC development. It is known that biofilms are surface-associated communities of bacteria that are embedded in a hydrated matrix of extracellular polymeric substances. Biofilms pose a substantial health risk and are key contributors to many chronic and recurrent infections. This link between biofilm-associated bacteria (e.g., Helicobacter pylori) and chronic infections likely arises from an increased tolerance to conventional antibiotic treatments as well as immune system activity. One of the major sugar antigens loosely attached to the cell surface is EPS. Polysaccharide capsule, piluses and the type VII secretion system were indicated as the main determinants of Sgg-specific association with endocarditis and CRC [11,12,13].
Exopolysaccharides of S. bovis are poorly characterized molecules. Until now, only the single S. macedonicus Sc136 EPS [15] structure was known among the entire S. bovis group. The S. macedonicus Sc136 strain, found in Greek sheep and goat cheeses, produces a high-molecular-mass, highly texturizing EPS built of hexasaccharide repeating units consisting of D-glucose, D-galactose and N-acetyl-D-glucosamine [15].
In this study, we have determined the structure of the EPS produced by S. gallolyticus subsp. gallolyticus for the first time. The repeating unit building the Sgg DSM 13808 EPS was elucidated as the hexasaccharide composed of the four d-Glc and two l-Rha residues and phosphate group (Figure 1). These residues are common constituents found in sugar surface antigens. The Glc and Rha residues, together with the phosphate group, have been previously identified as components (e.g., the S. pneumoniae 16F capsular polysaccharide [18] and the Lactobacillus sake 0-1 EPS [26]) but to differ in sequence and sugar substitution.
An interesting feature of Sgg 13808 EPS is the presence of a phosphate group at the reducing end of the EPS, identified before, e.g., for Hafnia alvei PCM 1195 O-antigen [27] and capsular polysaccharide of Pasteurella haemolytica serotype A7 [28]. Phosphate groups are essential for conformation of the entire EPS molecule as carriers of negative charges, playing an important role stabilizing the bacterial cell surface by interacting with doubly charged Ca2+ and Mg2+ ions.
Presented herein for the first time, the EPS structure of S. gallolyticus subsp. gallolyticys DSM 13808 broadens the knowledge regarding S. bovis exopolysaccharides and may help to understand the importance of bacterial surface structures factors, including sugar antigens, in the aetiology and pathogenesis of infectious diseases and hypothesized connection with CRC.

4. Materials and Methods

4.1. Bacteria

Streptococcus gallolyticus subsp. gallolyticus DSM 13808 (previously known as S. bovis biotype I) was isolated from anaerobic digester fed with shea cake and was obtained from the German Collection of Microorganisms and Cell Cultures GmbH (Brunswick, Germany). Bacteria were grown for 24 h in brain–heart infusion broth (10 l) at 37 °C.

4.2. Exopolysaccharide

The EPS was isolated and purified as previously described [16] with the following modification. Lyophilized bacteria (4.69 g) were extracted with 10% TCA (25 °C, 2.5 h) and then centrifuged (13,000× g, 4 °C, 20 min). EPS was precipitated from obtained supernatant with five volumes of cold 96% ethanol (4 °C, overnight) and finally centrifuged (13,500× g, 20 min). The pellet suspended in water was dialysed extensively for 48 h against water and then freeze-dried. Crude EPS dissolved in buffer (50 mM Tris–HCl pH 7.5, 10 mM MgCl2) was treated with DNase and RNase (37 °C, 6 h) and with protease from Streptomyces griseus (37 °C, overnight, SIGMA), then dialysed against water at 4 °C for 24 h. The EPS was purified by size-exclusion chromatography on a HiLoad Superdex 30 pg column (1.6 × 60 cm) equilibrated with 0.05 M acetic acid. A Shodex (RI 102) differential refractometer (Showa Denko Europe GmbH, Munich, Germany) was used for monitoring of eluates. After lyophilisation, first predominant fraction (3.6 mg) was used for further analysis.

4.3. Partial Acid Hydrolysis

A sample of the EPS (0.2 mg) was hydrolysed with 48% HF (0.2 mL) at −20 °C for 24 h and checked by MALDI-TOF MS after lyophilisation.

4.4. Analytical Methods

Monosaccharides were determined as their alditol acetates by GC–MS [29]. Partially methylated alditol acetates were examined as described by Ciucanu and Kerek [30] by GC–MS. Thermo Scientific ITQ system using a ZebronTM ZB-5HT (Thermo Fisher Scientific, Waltham, MA, USA) GC Capillary Column (30 m × 0.25 mm × 0.25 μm) was used with temperature program gradient from 150 to 270 °C at 8 °C/min. The absolute configurations were determined using (−)-2-butanol for the formation of 2-butyl glycosides [31,32]. The average molecular mass of the EPS was measured by gel permeation chromatography on an OHpak SB-806M HQ column (8 × 300 mm, Shodex, Showa Denko Europe GmbH, Munich, Germany) calibrated with dextran standards (Mw 1, 5, 12, 25, 50, 80, 150 and 270 kDa) and equilibrated with 0.1 M ammonium acetate buffer. The column eluate was monitored with a refractive index detector (RI 102; Shodex).

4.5. NMR Spectroscopy

NMR spectra were recorded with Avance III 600 MHz spectrometer (Bruker BioSpin, Rheinstetten, Germany) using 5 mm QCI cryoprobe; 3 mm tubes (~160 μL). The EPS sample was three times repeatedly exchanged with D2O (99%) and freeze-dried. NMR spectra were obtained of D2O solutions at 25 °C. Internal reference was applied using acetone (2.225 ppm, 31.05 ppm). The NMR signals were assigned by set of experiments (COSY, TOCSY, NOESY, HMBC, HSQC-TOCSY and HSQC-DEPT) using the NMRFAM-SPARKY program [33]. The JC-1,H-1 constant values were achieved from a non-decoupled HSQC-DEPT experiment. The TOCSY experiments were run with the mixing times 30, 60 and 100 ms. The delay time in the HMBC experiment was set to 60 ms, and the mixing time in the NOESY experiment was 200 ms. 1H,31P HMBC NMR spectrum was recorded for observation of phosphate groups by using Standard Bruker software (Bruker BioSpin GmbH, Rheinstetten, Germany), used for acquiring and processing.

4.6. Mass Spectrometry

The MALDI-TOF mass spectra were obtained in a positive ion mode by using an Ultraflextreme (Bruker, Bremen, Germany) mass spectrometer. Samples were dissolved in water (1 mg/mL). The 2,5-Dihydroxybenzoic acid (10 mg/mL in 1:1 AcN/0.2 M citric acid [v/v]) was used as a matrix. MALDI TOF/TOF MS analysis was performed by LIFT mode with the ion source voltage of 7.5 kV. The precursor ion mass window was set at 4 Da. The precursor ion was accelerated at 19.0 kV in the LIFT cell. The reflector voltage was set at 29.5 kV. External calibration was obtained with the Peptide Calibration Standard II (Bruker Daltonics, Germany). Ions were described according to the nomenclature of Domon and Costello [19].

Author Contributions

Conceptualisation, A.M. and C.L.; methodology, A.M. and C.L.; data analysis, A.M. and J.L.; investigation, A.M. and J.L.; writing—original draft preparation, A.M. and J.L.; writing—review and editing, A.M., J.L. and C.L.; supervision, A.M.; project administration, A.M.; funding acquisition, A.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Science Centre, Poland, grant number 2018/02/X/NZ6/02532.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors wish to thank Jaroslaw Ciekot for determination of the average molecular mass of the EPS.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript or in the decision to publish the results.

Abbreviations

EPSexopolysaccharide
TCAtrichloroacetic acid
MALDI-TOFmatrix-assisted laser-desorption/ionisation time-of-flight
MSmass spectrometry
NMRnuclear magnetic resonance
COSYcorrelated spectroscopy
TOCSYtotal correlation spectroscopy
NOESYnuclear Overhauser effect spectroscopy
HMBCheteronuclear multiple bond correlation
HSQCheteronuclear single quantum coherence
DEPTdistortionless enhancement by polarisation transfer
CRCcolorectal cancer
DSMZGerman Collection of Microorganisms and Cell Cultures GmbH

References

  1. Chaturvedi, A.K. Beyond Cervical Cancer: Burden of Other HPV-Related Cancers among Men and Women. J. Adolesc. Health 2010, 46 (Suppl. S4), S20–S26. [Google Scholar] [CrossRef]
  2. Suerbaum, S.; Michetti, P. Helicobacter Pylori Infection. N. Engl. J. Med. 2002, 347, 1175–1186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Siegel, R.L.; Miller, K.D.; Fuchs, H.E.; Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 2021, 71, 7–33. [Google Scholar] [CrossRef] [PubMed]
  4. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
  5. Xi, Y.; Xu, P. Global Colorectal Cancer Burden in 2020 and Projections to 2040. Transl. Oncol. 2021, 14, 101174. [Google Scholar] [CrossRef] [PubMed]
  6. Dumke, J.; Hinse, D.; Vollmer, T.; Knabbe, C.; Dreier, J. Development and Application of a Multilocus Sequence Typing Scheme for Streptococcus Gallolyticus Subsp. Gallolyticus. J. Clin. Microbiol. 2014, 52, 2472–2478. [Google Scholar] [CrossRef] [Green Version]
  7. Romero, B.; Morosini, M.-I.; Loza, E.; Rodríguez-Baños, M.; Navas, E.; Cantón, R.; Campo, R.D. Reidentification of Streptococcus Bovis Isolates Causing Bacteremia According to the New Taxonomy Criteria: Still an Issue? J. Clin. Microbiol. 2011, 49, 3228–3233. [Google Scholar] [CrossRef] [Green Version]
  8. Boleij, A.; Tjalsma, H. The Itinerary of Streptococcus Gallolyticus Infection in Patients with Colonic Malignant Disease. Lancet Infect. Dis. 2013, 13, 719–724. [Google Scholar] [CrossRef]
  9. Butt, J.; Romero-Hernández, B.; Pérez-Gómez, B.; Willhauck-Fleckenstein, M.; Holzinger, D.; Martin, V.; Moreno, V.; Linares, C.; Dierssen-Sotos, T.; Barricarte, A.; et al. Association of Streptococcus Gallolyticus Subspecies Gallolyticus with Colorectal Cancer: Serological Evidence. Int. J. Cancer 2016, 138, 1670–1679. [Google Scholar] [CrossRef] [Green Version]
  10. Kumar, R.; Herold, J.L.; Taylor, J.; Xu, J.; Xu, Y. Variations among Streptococcus Gallolyticus Subsp. Gallolyticus Strains in Connection with Colorectal Cancer. Sci. Rep. 2018, 8, 1514. [Google Scholar] [CrossRef]
  11. Isenring, J.; Köhler, J.; Nakata, M.; Frank, M.; Jans, C.; Renault, P.; Danne, C.; Dramsi, S.; Kreikemeyer, B.; Oehmcke-Hecht, S. Streptococcus Gallolyticus Subsp. Gallolyticus Endocarditis Isolate Interferes with Coagulation and Activates the Contact System. Virulence 2018, 9, 248–261. [Google Scholar] [CrossRef] [Green Version]
  12. Boleij, A.; Muytjens, C.M.J.; Bukhari, S.I.; Cayet, N.; Glaser, P.; Hermans, P.W.M.; Swinkels, D.W.; Bolhuis, A.; Tjalsma, H. Novel Clues on the Specific Association of Streptococcus Gallolyticus Subsp Gallolyticus with Colorectal Cancer. J. Infect. Dis. 2011, 203, 1101–1109. [Google Scholar] [CrossRef]
  13. Taylor, J.C.; Gao, X.; Xu, J.; Holder, M.; Petrosino, J.; Kumar, R.; Liu, W.; Höök, M.; Mackenzie, C.; Hillhouse, A.; et al. A Type VII Secretion System of Streptococcus Gallolyticus Subsp. Gallolyticus Contributes to Gut Colonization and the Development of Colon Tumors. PLoS Pathog. 2021, 17, e1009182. [Google Scholar] [CrossRef]
  14. Molinari, A.; Orefici, G.; Donelli, G.; Von Hunolstein, C.; Paradisi, S.; Arancia, G. Preservation of Capsular Material of Streptococcal Cells by Specific Lectins Determined by Immunoelectron Microscopy. Histochem. J. 1988, 20, 526–530. [Google Scholar] [CrossRef]
  15. Vincent, S.J.; Faber, E.J.; Neeser, J.R.; Stingele, F.; Kamerling, J.P. Structure and Properties of the Exopolysaccharide Produced by Streptococcus Macedonicus Sc136. Glycobiology 2001, 11, 131–139. [Google Scholar] [CrossRef] [Green Version]
  16. Górska, S.; Jachymek, W.; Rybka, J.; Strus, M.; Heczko, P.B.; Gamian, A. Structural and Immunochemical Studies of Neutral Exopolysaccharide Produced by Lactobacillus Johnsonii 142. Carbohydr. Res. 2010, 345, 108–114. [Google Scholar] [CrossRef]
  17. Jachymek, W.; Petersson, C.; Helander, A.; Kenne, L.; Lugowski, C.; Niedziela, T. Structural Studies of the O-Specific Chain and a Core Hexasaccharide of Hafnia Alvei Strain 1192 Lipopolysaccharide. Carbohydr. Res. 1995, 269, 125–138. [Google Scholar] [CrossRef]
  18. Li, C.; Duda, K.A.; Elverdal, P.L.; Skovsted, I.C.; Kjeldsen, C.; Duus, J.Ø. Structural, Biosynthetic, and Serological Cross-Reactive Elucidation of Capsular Polysaccharides from Streptococcus Pneumoniae Serogroup 16. J. Bacteriol. 2019, 201, e00453-19. [Google Scholar] [CrossRef] [Green Version]
  19. Domon, B.; Costello, C.E. A Systematic Nomenclature for Carbohydrate Fragmentations in FAB-MS/MS Spectra of Glycoconjugates. Glycoconj. J. 1988, 5, 397–409. [Google Scholar] [CrossRef]
  20. Verma, D.K.; Niamah, A.K.; Patel, A.R.; Thakur, M.; Singh Sandhu, K.; Chávez-González, M.L.; Shah, N.; Noe Aguilar, C. Chemistry and Microbial Sources of Curdlan with Potential Application and Safety Regulations as Prebiotic in Food and Health. Food Res. Int. Ott. Ont 2020, 133, 109136. [Google Scholar] [CrossRef]
  21. Wang, K.; Li, W.; Rui, X.; Chen, X.; Jiang, M.; Dong, M. Characterization of a Novel Exopolysaccharide with Antitumor Activity from Lactobacillus Plantarum 70810. Int. J. Biol. Macromol. 2014, 63, 133–139. [Google Scholar] [CrossRef]
  22. Alvarez, X. Biochemical Characterization of Nostoc Sp. Exopolysaccharides and Evaluation of Potential Use in Wound Healing. Carbohydr. Polym. 2020, 254, 117303. [Google Scholar] [CrossRef]
  23. Ciszek-Lenda, M.; Strus, M.; Górska, S.; Targosz-Korecka, M.; Śróttek, M.; Heczko, P.; Gamian, A.; Szymonski, M.; Marcinkiewicz, J. Strain Specific Immunostimulatory Potential of Lactobacilli-Derived Exopolysaccharides. Cent.-Eur. J. Immunol. 2011, 36, 121–129. [Google Scholar]
  24. Fanning, S.; Hall, L.J.; van Sinderen, D. Bifidobacterium Breve UCC2003 Surface Exopolysaccharide Production Is a Beneficial Trait Mediating Commensal-Host Interaction through Immune Modulation and Pathogen Protection. Gut Microbes 2012, 3, 420–425. [Google Scholar] [CrossRef] [Green Version]
  25. Górska, S.; Schwarzer, M.; Jachymek, W.; Srutkova, D.; Brzozowska, E.; Kozakova, H.; Gamian, A. Distinct Immunomodulation of Bone Marrow-Derived Dendritic Cell Responses to Lactobacillus Plantarum WCFS1 by Two Different Polysaccharides Isolated from Lactobacillus Rhamnosus LOCK 0900. Appl. Environ. Microbiol. 2014, 80, 6506–6516. [Google Scholar] [CrossRef] [Green Version]
  26. Laws, A.; Gu, Y.; Marshall, V. Biosynthesis, Characterisation, and Design of Bacterial Exopolysaccharides from Lactic Acid Bacteria. Biotechnol. Adv. 2001, 19, 597–625. [Google Scholar] [CrossRef]
  27. Niedziela, T.; Kenne, L.; Lugowski, C. Novel O-Antigen of Hafnia Alvei PCM 1195 Lipopolysaccharide with a Teichoic Acid-like Structure. Carbohydr. Res. 2010, 345, 270–274. [Google Scholar] [CrossRef]
  28. Adlam, C.; Knights, J.M.; Mugridge, A.; Lindon, J.C.; Williams, J.M.; Beesley, J.E.Y. 1986. Purification, Characterization and Immunological Properties of the Serotype-Specific Capsular Polysaccharide of Pasteurella Haemolytica Serotype A7 Organisms. Microbiology 1986, 132, 1079–1087. [Google Scholar] [CrossRef] [Green Version]
  29. Petersson, C.; Niedziela, T.; Jachymek, W.; Kenne, L.; Zarzecki, P.; Lugowski, C. Structural Studies of the O-Specific Polysaccharide of Hafnia Alvei Strain PCM 1206 Lipopolysaccharide Containing D-Allothreonine. Eur. J. Biochem. 1997, 244, 580–586. [Google Scholar] [CrossRef]
  30. Ciucanu, I.; Kerek, F. A Simple and Rapid Method for the Permethylation of Carbohydrates. Carbohydr. Res. 1984, 131, 209–217. [Google Scholar] [CrossRef]
  31. Gerwig, G.J.; Kamerling, J.P.; Vliegenthart, J.F.G. Determination of the d and l Configuration of Neutral Monosaccharides by High-Resolution Capillary g.l.c. Carbohydr. Res. 1978, 62, 349–357. [Google Scholar] [CrossRef]
  32. Gerwig, G.J.; Kamerling, J.P.; Vliegenthart, J.F. Determination of the Absolute Configuration of Mono-Saccharides in Complex Carbohydrates by Capillary G.L.C. Carbohydr. Res. 1979, 77, 10–17. [Google Scholar] [CrossRef] [Green Version]
  33. Lee, W.; Tonelli, M.; Markley, J.L. NMRFAM-SPARKY: Enhanced Software for Biomolecular NMR Spectroscopy. Bioinforma. Oxf. Engl. 2015, 31, 1325–1327. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The structure and 1H NMR spectrum of the EPS isolated from S. gallolyticus DSM 13808. The capital letters refer to carbohydrate residues, as shown in the inset structure and Table 1. The Arabic numerals refer to protons in respective residues. Letter A′ presents a variant of the residue A due to the lack of a phosphate group at the reducing end, affecting the presence of residue B′ instead of residue B.
Figure 1. The structure and 1H NMR spectrum of the EPS isolated from S. gallolyticus DSM 13808. The capital letters refer to carbohydrate residues, as shown in the inset structure and Table 1. The Arabic numerals refer to protons in respective residues. Letter A′ presents a variant of the residue A due to the lack of a phosphate group at the reducing end, affecting the presence of residue B′ instead of residue B.
Ijms 23 11797 g001
Figure 2. Selected regions of 1H,13C HSQC-DEPT and HMBC spectra of the EPS. The capital letters refer to carbohydrate residues, as shown in Figure 1 and Table 1. The Arabic numerals refer to protons and carbons in respective residues. Residues A′, A″ and residues B′, B″ are variants of residues A and B, respectively, due to the lack of a phosphate group at the reducing end.
Figure 2. Selected regions of 1H,13C HSQC-DEPT and HMBC spectra of the EPS. The capital letters refer to carbohydrate residues, as shown in Figure 1 and Table 1. The Arabic numerals refer to protons and carbons in respective residues. Residues A′, A″ and residues B′, B″ are variants of residues A and B, respectively, due to the lack of a phosphate group at the reducing end.
Ijms 23 11797 g002
Figure 3. Selected region of 1H,31P HMBC spectrum of the EPS.
Figure 3. Selected region of 1H,31P HMBC spectrum of the EPS.
Ijms 23 11797 g003
Figure 4. Positive ion mode MALDI-TOF mass spectra of the partially hydrolysed EPS (A), and the MS/MS fragmentation of the ion at m/z 1061.29 (1+) attributed to the hexasaccharide repeating unit linked to phosphate group accompanied by the EPS inset structure explaining interpretation of the fragment ions (B). The RU·P and RU symbols stand for the one repeating unit of the EPS with or without P, respectively. The m/z values represent single charged ions. The fragment ions were presented according to the nomenclature of Domon and Costello [19].
Figure 4. Positive ion mode MALDI-TOF mass spectra of the partially hydrolysed EPS (A), and the MS/MS fragmentation of the ion at m/z 1061.29 (1+) attributed to the hexasaccharide repeating unit linked to phosphate group accompanied by the EPS inset structure explaining interpretation of the fragment ions (B). The RU·P and RU symbols stand for the one repeating unit of the EPS with or without P, respectively. The m/z values represent single charged ions. The fragment ions were presented according to the nomenclature of Domon and Costello [19].
Ijms 23 11797 g004
Table 1. The 1H and 13C NMR chemical shifts and selected inter-residue correlations from NOESY and HMBC spectra of the EPS isolated from S. gallolyticus DSM 13808.
Table 1. The 1H and 13C NMR chemical shifts and selected inter-residue correlations from NOESY and HMBC spectra of the EPS isolated from S. gallolyticus DSM 13808.
Residue (a)Chemical Shifts (ppm)Selected Inter-Residue NOE and 3JH,C Connectivities
H1
C1
H2,
C2
H3
C3
H4
C4
H5
C5
H6a, H6b
C6
H1/C1
Connectivities to
Inter-Residue Atom/Residue
A→2)-α-d-Glcp-(1→P (b)5.58
95.5
3.61
79.7
3.86
72.8
3.55
69.7
3.85
73.6
3.81 (c)
61.0
--
A′→2)-α-d-Glcp-(1→5.31
92.2
3.54
80.7
3.78
72.8
3.45
70.4
3.85
71.8
3.88, 3.84
61.3
--
A″→2)-β-d-Glcp-(1→4.71
95.6
3.33
81.3
3.58
77.1
3.44
70.1
nd (d)nd (d)--
B→2,3)-α-l-Rhap-(1→5.29
102.2
4.49
79.4
4.07
80.7
3.65
71.9
3.95
70.0
1.33
17.7
3.61
79.7
H2 of A
B′→2,3)-α-l-Rhap-(1→5.26
102.2
4.47
79.4
4.07
80.5
3.67
71.8
3.88
69.9
1.31
17.4
3.54
80.7
H2 of A′
B″→2,3)-α-l-Rhap-(1→5.39
101.0
4.42
79.6
4.00
80.5
3.68
71.8
3.85
69.7
1.28
17.4
3.33
81.3
H2 of A″
CP→6)-α-d-Glcp-(1→5.10
96.5
3.61
72.2
3.80
73.5
3.55
69.7
4.10
71.5
4.16, 4.08
64.9
3.69
78.6
H3 of D
D→3)-β-l-Rhap-(1→4.88
101.4
4.30
68.3
3.69
78.6
3.46
71.1
3.45
73.0
1.34
17.6
3.68
77.4
H4 of F
Eβ-d-Glcp-(1→4.72
104.7
3.34
74.2
3.50
76.4
3.43
70.1
3.43
76.5
3.87, 3.75
61.2
4.49
79.4
H2 of B
F→4)-β-d-Glcp-(1→4.71
104.5
3.37
74.2
3.67
76.2
3.68
77.4
3.55
75.2
3.96, 3.89
61.4
4.07
80.7
H3 of B
(a) The JC-1,H-1 constants 173, 172, 162, 176, 174, 173, 170, 162, 161 and 163 Hz were observed for A, A′, A″, B, B″, C, D, E and F residues, respectively. (b) The 31P resonance at δP −1.02 ppm showed connectivity to the H1 of residue A and H6a; H6b of residue C indicated the phosphodiester group. Residues A′ and A″ were recognized as α and β variants of residue A due to the lack of a phosphate group at the reducing end of the EPS, which affected the adjacent residues B′ and B″, recognized as variants of residue B. The 31P signal at δ 0.95 ppm showed connectivity only to H6a and H6b of residue C′, indicating phosphomonoester at the non-reducing end of the EPS. (c) Not resolved. (d) Not determined.
Table 2. Interpretation of positive ion mode MALDI-TOF mass spectra of the partially hydrolysed EPS (Figure 4A) and the MS/MS fragmentation of the hexasaccharide represented by the ion at m/z 1061.29 (inset structure) (Figure 4B).
Table 2. Interpretation of positive ion mode MALDI-TOF mass spectra of the partially hydrolysed EPS (Figure 4A) and the MS/MS fragmentation of the hexasaccharide represented by the ion at m/z 1061.29 (inset structure) (Figure 4B).
Oligosaccharide StructureCalculated Mass (Da)Observed Ion (m/z)Calculated Ion (m/z)Interpretation
of the Ion
Glc8·Rha4·P22058.602125.542125.55[M + H, 3Na]+
Glc8·Rha4·P1978.632023.612023.60[M + H, 2Na]+
Glc8·Rha41898.661921.661921.65[M + H, Na]+
Glc4·Rha2·P1038.301083.271083.28[M + H, 2Na]+
Glc4·Rha2·P1038.301061.291061.29[M + H, Na]+
Glc4·Rha2·P1038.301043.391043.28[M–H2O + H, Na]+
Glc4·Rha2958.34981.29981.33[M + H, Na]+
Glc4·Rha2958.34963.46963.31[M–H2O + H, Na]+
Glc3·Rha2·P876.25899.02899.24[M + H, Na]+
Glc3·Rha2·P876.25881.12881.23[M–H2O + H, Na]+
Glc3·Rha2796.28819.11819.27[M + H, Na]+
Glc3·Rha2796.28801.17801.26[M–H2O + H, Na]+
Glc3·Rha2796.28783.03783.26[M–2H2O + H, Na]+
Glc2·Rha2·P714.20718.98719.18[M–H2O + H, Na]+
Glc3·Rha650.23673.07673.22[M + H, Na]+
Glc3·Rha650.23655.04655.20[M–H2O + H, Na]+
Glc2·Rha·P568.14590.92591.13[M + H, Na]+
Glc2·Rha·P568.14572.90573.12[M–H2O + H, Na]+
Glc2·Rha488.17510.95511.16[M + H, Na]+
Glc2·Rha488.17492.95493.15[M–H2O + H, Na]+
Glc·Rha·P406.09432.88433.05[M–H2O + H, 2Na]+
Glc·Rha·P406.09410.87411.06[M–H2O + H, Na]+
Glc·Rha309.12330.92331.11[M + H, Na]+
Glc·P242.02304.79305.00[M + H, 2Na]+
Glc·P242.02286.86287.01[M–H2O + H, 2Na]+
Glc·P242.02264.84265.02[M + H, Na]+
Glc180.06202.97203.05[M + H, Na]+
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Maciejewska, A.; Lugowski, C.; Lukasiewicz, J. First Report on the Streptococcus gallolyticus (S. bovis Biotype I) DSM 13808 Exopolysaccharide Structure. Int. J. Mol. Sci. 2022, 23, 11797. https://doi.org/10.3390/ijms231911797

AMA Style

Maciejewska A, Lugowski C, Lukasiewicz J. First Report on the Streptococcus gallolyticus (S. bovis Biotype I) DSM 13808 Exopolysaccharide Structure. International Journal of Molecular Sciences. 2022; 23(19):11797. https://doi.org/10.3390/ijms231911797

Chicago/Turabian Style

Maciejewska, Anna, Czeslaw Lugowski, and Jolanta Lukasiewicz. 2022. "First Report on the Streptococcus gallolyticus (S. bovis Biotype I) DSM 13808 Exopolysaccharide Structure" International Journal of Molecular Sciences 23, no. 19: 11797. https://doi.org/10.3390/ijms231911797

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop